Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders
HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenous...
Saved in:
Published in | Neurobiology of disease Vol. 55; pp. 110 - 119 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.07.2013
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0969-9961 1095-953X 1095-953X |
DOI | 10.1016/j.nbd.2013.02.004 |
Cover
Abstract | HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND.
► The pathogenesis of HIV-1 associated neurocognitive disorders (HAND) is unclear. ► Neurochemistry and susceptibility to seizures were studied in tat transgenic mice. ► Data suggest that tat expression in the brain causes a latent hyper-excitability state. ► Tat-induced hyper-excitability may play a key role in HAND development. |
---|---|
AbstractList | HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND.HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND. HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND. HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND. ► The pathogenesis of HIV-1 associated neurocognitive disorders (HAND) is unclear. ► Neurochemistry and susceptibility to seizures were studied in tat transgenic mice. ► Data suggest that tat expression in the brain causes a latent hyper-excitability state. ► Tat-induced hyper-excitability may play a key role in HAND development. Abstract HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat -transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND. |
Author | Cifelli, Pierangelo Pittaluga, Anna Caputo, Antonella Brocca-Cofano, Egidio Fabris, Marina Altavilla, Giuseppe Simonato, Michele Busatto, Graziella Zucchini, Silvia Summa, Maria Bonaccorsi, Angela Barbanti-Brodano, Giuseppe Verlengia, Gianluca Corallini, Alfredo De Michele, Rita |
Author_xml | – sequence: 1 givenname: Silvia surname: Zucchini fullname: Zucchini, Silvia email: silvia.zucchini@unife.it organization: Department of Medical Sciences, Neuroscience Center, University of Ferrara, National Institute of Neuroscience, Italy – sequence: 2 givenname: Anna surname: Pittaluga fullname: Pittaluga, Anna organization: Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genoa, Italy – sequence: 3 givenname: Egidio surname: Brocca-Cofano fullname: Brocca-Cofano, Egidio organization: Department of Molecular Medicine, University of Padua, Italy – sequence: 4 givenname: Maria surname: Summa fullname: Summa, Maria organization: Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genoa, Italy – sequence: 5 givenname: Marina surname: Fabris fullname: Fabris, Marina organization: Department of Molecular Medicine, University of Padua, Italy – sequence: 6 givenname: Rita surname: De Michele fullname: De Michele, Rita organization: Department of Molecular Medicine, University of Padua, Italy – sequence: 7 givenname: Angela surname: Bonaccorsi fullname: Bonaccorsi, Angela organization: Department of Molecular Medicine, University of Padua, Italy – sequence: 8 givenname: Graziella surname: Busatto fullname: Busatto, Graziella organization: Department of Medicine, University of Padua, Italy – sequence: 9 givenname: Giuseppe surname: Barbanti-Brodano fullname: Barbanti-Brodano, Giuseppe organization: Department of Experimental and Diagnostic Medicine, Section of Microbiology, University of Ferrara, Italy – sequence: 10 givenname: Giuseppe surname: Altavilla fullname: Altavilla, Giuseppe organization: Department of Medicine, University of Padua, Italy – sequence: 11 givenname: Gianluca surname: Verlengia fullname: Verlengia, Gianluca organization: Department of Medical Sciences, Neuroscience Center, University of Ferrara, National Institute of Neuroscience, Italy – sequence: 12 givenname: Pierangelo surname: Cifelli fullname: Cifelli, Pierangelo organization: Department of Medical Sciences, Neuroscience Center, University of Ferrara, National Institute of Neuroscience, Italy – sequence: 13 givenname: Alfredo surname: Corallini fullname: Corallini, Alfredo organization: Department of Experimental and Diagnostic Medicine, Section of Microbiology, University of Ferrara, Italy – sequence: 14 givenname: Antonella surname: Caputo fullname: Caputo, Antonella organization: Department of Molecular Medicine, University of Padua, Italy – sequence: 15 givenname: Michele surname: Simonato fullname: Simonato, Michele organization: Department of Medical Sciences, Neuroscience Center, University of Ferrara, National Institute of Neuroscience, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23454193$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl1rFDEUhoNU7Hb1B3gjc-nNrCeTzEcUBClqFwqCX3gXzyRnlqyzSU1mxf33ZtzWi4LtVUjyPm9CnpyxEx88MfaUw4oDb15sV763qwq4WEG1ApAP2IKDqktVi28nbAGqUaVSDT9lZyltATivVfuInVZC1pIrsWDf195EwkS2oN_GTdi70U2HwvliwqmcIvq0Ie9MsXOGXhYfw0hFGObNOXOx_lpGGnHKvKd9DGPYOINjYV0K0VJMj9nDAcdET67HJfvy7u3n84vy8sP79fmby9I0AFPZ2LrrG0QrgEvsmsa0zSCHCvuuRZTCymrIs6ETwiqLleKy6S3UOJiqp64SS7Y-9tqAW30V3Q7jQQd0-u9CiBuNcXJmJF1bC6h4Z1UrpRpahTigAlkjdKLhInc9P3ZdxfBzT2nSO5cMjSN6CvukeQ3QdnWnuvujQqoWZFvNN3x2Hd33O7L_7ngjIwfaY8DEkFKkQc9CJhd81uBGzUHP2vVWZ-161q6h0ll7Jvkt8qb8LubVkaFs5ZejqJNx5A1ZF8lM-dncnfTrW7QZnZ_V_6ADpW3YR591a65TBvSn-SvOP5ELAGjyIy-Z-n_BPYf_AUEr69s |
CitedBy_id | crossref_primary_10_1007_s11481_016_9664_y crossref_primary_10_3390_microorganisms9122537 crossref_primary_10_1007_s11481_013_9518_9 crossref_primary_10_1096_fj_202101722R crossref_primary_10_1007_s12035_024_04113_8 crossref_primary_10_1016_j_neuropharm_2018_08_013 crossref_primary_10_1016_j_neulet_2021_135877 crossref_primary_10_1371_journal_pone_0305868 crossref_primary_10_1371_journal_ppat_1008249 crossref_primary_10_1007_s12035_019_1511_8 crossref_primary_10_1016_j_bbi_2023_07_021 crossref_primary_10_1007_s00018_021_03785_y crossref_primary_10_3389_fcimb_2020_00261 crossref_primary_10_3389_fnmol_2017_00163 crossref_primary_10_3389_fnmol_2022_870868 crossref_primary_10_1098_rsob_200286 crossref_primary_10_1016_j_bpsc_2017_04_002 crossref_primary_10_3390_brainsci7040038 crossref_primary_10_3389_fimmu_2017_01079 crossref_primary_10_1124_jpet_124_002272 crossref_primary_10_1016_j_ijdevneu_2017_10_009 crossref_primary_10_3389_fnins_2016_00497 crossref_primary_10_1002_glia_24033 crossref_primary_10_1038_s41598_019_44463_1 crossref_primary_10_1007_s10495_014_1003_2 crossref_primary_10_3389_fnins_2018_00921 crossref_primary_10_3390_cells11193035 crossref_primary_10_3389_fnmol_2018_00324 crossref_primary_10_3389_fphar_2016_00295 crossref_primary_10_3390_ijms21103631 crossref_primary_10_1016_j_nbd_2017_04_015 |
Cites_doi | 10.1073/pnas.95.22.13153 10.1002/ana.410330604 10.1016/S0197-0186(96)00129-5 10.1182/blood.V93.6.1851.406k12_1851_1857 10.1002/glia.20708 10.1016/j.biopsych.2006.08.003 10.1097/00001756-200211150-00016 10.1126/science.285.5433.1569 10.1124/jpet.108.150144 10.1016/j.neulet.2010.09.019 10.1038/sj.cdd.4401623 10.1523/JNEUROSCI.1472-08.2008 10.1016/S0002-9440(10)65375-8 10.1523/JNEUROSCI.23-17-06810.2003 10.1046/j.1471-4159.2001.00396.x 10.1023/B:NERE.0000021241.90133.89 10.1016/j.jneuroim.2009.09.014 10.1016/0028-3908(92)90085-4 10.1016/j.brainres.2004.03.037 10.1093/cercor/bhp274 10.1128/JVI.65.2.961-967.1991 10.1073/pnas.0611699104 10.1016/j.micinf.2005.11.014 10.1016/S0022-510X(02)00155-7 10.1016/S0006-8993(00)02513-0 10.1097/00005072-199806000-00004 10.1038/375497a0 10.1016/j.neuroscience.2007.11.031 10.1016/S0304-3940(01)01786-4 10.1016/j.neuropharm.2007.04.006 10.1046/j.1471-4159.2003.01775.x 10.1016/S0301-0082(97)00053-1 10.1523/JNEUROSCI.22-22-10030.2002 10.1016/0006-8993(86)91464-2 10.1111/j.1750-3639.1999.tb00219.x 10.1046/j.1471-4159.1999.0731363.x 10.1128/JVI.67.1.277-287.1993 10.1016/0092-8674(88)90263-2 10.1111/j.1471-4159.2011.07223.x 10.1016/j.ncl.2009.09.018 10.1006/bbrc.1999.1894 10.1007/s11481-010-9205-z 10.1124/jpet.105.099630 10.1006/exnr.2002.8048 10.1016/S0306-4522(97)00174-7 10.1016/S0002-9440(10)64304-0 10.1002/ana.410190602 10.1097/00002030-199712000-00006 10.1001/archneur.56.1.111 10.1016/j.neuroscience.2009.01.024 10.1523/JNEUROSCI.3019-08.2008 10.1002/ana.410320304 10.1016/j.virol.2007.02.004 10.1016/S1525-0016(03)00122-9 10.1016/j.nbd.2011.10.005 10.3109/13550280009013158 10.1074/jbc.275.6.4159 10.1073/pnas.0810710106 10.1023/A:1007648229795 10.1016/S0006-8993(02)03360-7 10.1016/0003-2697(76)90527-3 10.1002/jnr.21446 10.1126/science.2990040 10.1523/JNEUROSCI.18-06-02004.1998 10.1126/science.2148832 10.1016/S0140-6736(06)68075-6 |
ContentType | Journal Article |
Copyright | 2013 Elsevier Inc. Elsevier Inc. Copyright © 2013 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2013 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2013 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7TK 8FD FR3 P64 RC3 DOA |
DOI | 10.1016/j.nbd.2013.02.004 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Genetics Abstracts Engineering Research Database Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE - Academic Genetics Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1095-953X |
EndPage | 119 |
ExternalDocumentID | oai_doaj_org_article_5dd0a918d97449f79aafa9045a083613 23454193 10_1016_j_nbd_2013_02_004 S0969996113000661 1_s2_0_S0969996113000661 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1~. 1~5 29N 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABFRF ABJNI ABMAC ABMZM ABTEW ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADVLN ADXHL AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AIEXJ AIGII AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU G-Q GBLVA GROUPED_DOAJ HVGLF HZ~ IHE J1W K-O KOM M41 MO0 MOBAO N9A O-L O9- OAUVE OK1 OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SES SEW SSH SSN SSZ T5K X7M XPP Z5R ZGI ZMT ZU3 ~G- 0SF 6I. AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ PKN RIG AADPK AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 7TK 8FD FR3 P64 RC3 |
ID | FETCH-LOGICAL-c600t-6d58b6aad3014a866c76f4f2ab87aa43d42ff2af833d9da29146bd05afc2be823 |
IEDL.DBID | AIKHN |
ISSN | 0969-9961 1095-953X |
IngestDate | Wed Aug 27 00:58:35 EDT 2025 Fri Sep 05 14:31:35 EDT 2025 Thu Sep 04 22:09:31 EDT 2025 Thu Apr 03 06:54:55 EDT 2025 Tue Jul 01 03:07:21 EDT 2025 Thu Apr 24 23:11:58 EDT 2025 Fri Feb 23 02:29:35 EST 2024 Sun Feb 23 10:19:13 EST 2025 Tue Aug 26 16:32:24 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | HIV-1 associated neurocognitive disorders Kainate Neurodegeneration HIV-1-tat-transgenic mice Seizures |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2013 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c600t-6d58b6aad3014a866c76f4f2ab87aa43d42ff2af833d9da29146bd05afc2be823 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://doaj.org/article/5dd0a918d97449f79aafa9045a083613 |
PMID | 23454193 |
PQID | 1349704722 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_5dd0a918d97449f79aafa9045a083613 proquest_miscellaneous_1500785898 proquest_miscellaneous_1349704722 pubmed_primary_23454193 crossref_citationtrail_10_1016_j_nbd_2013_02_004 crossref_primary_10_1016_j_nbd_2013_02_004 elsevier_sciencedirect_doi_10_1016_j_nbd_2013_02_004 elsevier_clinicalkeyesjournals_1_s2_0_S0969996113000661 elsevier_clinicalkey_doi_10_1016_j_nbd_2013_02_004 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-07-01 |
PublicationDateYYYYMMDD | 2013-07-01 |
PublicationDate_xml | – month: 07 year: 2013 text: 2013-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Neurobiology of disease |
PublicationTitleAlternate | Neurobiol Dis |
PublicationYear | 2013 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Bonanno, Raiteri (bb0045) 1993; 262 King (bb0205) 2006; 8 Zucchini (bb0365) 2008; 49 Li (bb0210) 2008; 28 Schwarze (bb0315) 1999; 285 Flora (bb0135) 2003; 179 Eugenin (bb0100) 2003; 85 Frankel, Pabo (bb0140) 1988; 55 Modi (bb0245) 2002; 202 Gavriil (bb0145) 2000; 267 Mengozzi (bb0235) 1999; 93 Sabatier (bb0305) 1991; 65 Virgili (bb0335) 1992; 5 Luccini (bb0225) 2007; 85 Zhu (bb0355) 2009; 329 Eugenin (bb0105) 2007; 104 Raiteri, Raiteri (bb0300) 2000; 25 Tattevin (bb0330) 2006; 367 Singer (bb0325) 2010; 28 Zucchini (bb0360) 2002; 13 Behnisch (bb0040) 2004; 1012 Bruce-Keller (bb0065) 2008; 56 Musante (bb0250) 2010; 20 Haughey (bb0170) 1999; 73 Navia, Jordan, Price (bb0270) 1986; 19 Brailoiu (bb0055) 2008; 151 Muzzolini (bb0260) 1997; 31 Peng (bb0285) 2010; 218 Bradford (bb0050) 1976; 72 Ferrari (bb0125) 2003; 8 Agrawal (bb0020) 2012; 45 Westendorp (bb0345) 1995; 375 Jones (bb0190) 1998; 57 Wessenligh (bb0340) 1993; 33 Kaul (bb0195) 2005; 12 Pittaluga (bb0290) 2007; 53 Gupta (bb0165) 2010; 485 Schmued, Hopkins (bb0310) 2000; 874 Bartolomei (bb0035) 1999; 56 Nath, Geiger (bb0265) 1998; 54 Musante (bb0255) 2011; 117 Feligioni (bb0120) 2003; 23 Minghetti (bb0240) 2004; 29 Aksenov (bb0010) 2001; 305 Selnes (bb0320) 2005; 15 Paxinos, Franklin (bb0280) 2001 Agrawal (bb0015) 2007; 363 Cheng (bb0075) 1998; 82 Fadda (bb0115) 2007; 62 Kim (bb0200) 2003; 162 Hudson (bb0180) 2000; 6 Paradiso (bb0275) 2009; 106 Haughey (bb0175) 2001; 78 Janumpalli (bb0185) 1998; 18 Lindl (bb0215) 2010; 5 Arya (bb0030) 1985; 229 Longordo (bb0220) 2006; 317 Dore (bb0085) 1996; 1 Giulian (bb0150) 1990; 250 Albini (bb0005) 1998; 95 Prendergast (bb0295) 2002; 954 Altavilla (bb0025) 1999; 154 Chang (bb0070) 1997; 12 Dunkley (bb0090) 1986; 372 Ensoli (bb0095) 1993; 67 Corallini (bb0080) 1993; 53 Masliah (bb0230) 1992; 32 Everall (bb0110) 1999; 9 Bregola (bb0060) 2002; 22 Zauli (bb0350) 2000; 275 Ferris (bb0130) 2009; 159 Ferris (10.1016/j.nbd.2013.02.004_bb0130) 2009; 159 Dunkley (10.1016/j.nbd.2013.02.004_bb0090) 1986; 372 Gavriil (10.1016/j.nbd.2013.02.004_bb0145) 2000; 267 King (10.1016/j.nbd.2013.02.004_bb0205) 2006; 8 Navia (10.1016/j.nbd.2013.02.004_bb0270) 1986; 19 Agrawal (10.1016/j.nbd.2013.02.004_bb0020) 2012; 45 Paxinos (10.1016/j.nbd.2013.02.004_bb0280) 2001 Westendorp (10.1016/j.nbd.2013.02.004_bb0345) 1995; 375 Nath (10.1016/j.nbd.2013.02.004_bb0265) 1998; 54 Zauli (10.1016/j.nbd.2013.02.004_bb0350) 2000; 275 Albini (10.1016/j.nbd.2013.02.004_bb0005) 1998; 95 Bartolomei (10.1016/j.nbd.2013.02.004_bb0035) 1999; 56 Tattevin (10.1016/j.nbd.2013.02.004_bb0330) 2006; 367 Corallini (10.1016/j.nbd.2013.02.004_bb0080) 1993; 53 Bregola (10.1016/j.nbd.2013.02.004_bb0060) 2002; 22 Janumpalli (10.1016/j.nbd.2013.02.004_bb0185) 1998; 18 Minghetti (10.1016/j.nbd.2013.02.004_bb0240) 2004; 29 Luccini (10.1016/j.nbd.2013.02.004_bb0225) 2007; 85 Flora (10.1016/j.nbd.2013.02.004_bb0135) 2003; 179 Longordo (10.1016/j.nbd.2013.02.004_bb0220) 2006; 317 Aksenov (10.1016/j.nbd.2013.02.004_bb0010) 2001; 305 Ensoli (10.1016/j.nbd.2013.02.004_bb0095) 1993; 67 Feligioni (10.1016/j.nbd.2013.02.004_bb0120) 2003; 23 Bruce-Keller (10.1016/j.nbd.2013.02.004_bb0065) 2008; 56 Schwarze (10.1016/j.nbd.2013.02.004_bb0315) 1999; 285 Brailoiu (10.1016/j.nbd.2013.02.004_bb0055) 2008; 151 Prendergast (10.1016/j.nbd.2013.02.004_bb0295) 2002; 954 Zhu (10.1016/j.nbd.2013.02.004_bb0355) 2009; 329 Mengozzi (10.1016/j.nbd.2013.02.004_bb0235) 1999; 93 Eugenin (10.1016/j.nbd.2013.02.004_bb0100) 2003; 85 Hudson (10.1016/j.nbd.2013.02.004_bb0180) 2000; 6 Dore (10.1016/j.nbd.2013.02.004_bb0085) 1996; 1 Selnes (10.1016/j.nbd.2013.02.004_bb0320) 2005; 15 Kaul (10.1016/j.nbd.2013.02.004_bb0195) 2005; 12 Frankel (10.1016/j.nbd.2013.02.004_bb0140) 1988; 55 Cheng (10.1016/j.nbd.2013.02.004_bb0075) 1998; 82 Masliah (10.1016/j.nbd.2013.02.004_bb0230) 1992; 32 Li (10.1016/j.nbd.2013.02.004_bb0210) 2008; 28 Paradiso (10.1016/j.nbd.2013.02.004_bb0275) 2009; 106 Raiteri (10.1016/j.nbd.2013.02.004_bb0300) 2000; 25 Fadda (10.1016/j.nbd.2013.02.004_bb0115) 2007; 62 Zucchini (10.1016/j.nbd.2013.02.004_bb0365) 2008; 49 Ferrari (10.1016/j.nbd.2013.02.004_bb0125) 2003; 8 Bradford (10.1016/j.nbd.2013.02.004_bb0050) 1976; 72 Bonanno (10.1016/j.nbd.2013.02.004_bb0045) 1993; 262 Lindl (10.1016/j.nbd.2013.02.004_bb0215) 2010; 5 Arya (10.1016/j.nbd.2013.02.004_bb0030) 1985; 229 Haughey (10.1016/j.nbd.2013.02.004_bb0170) 1999; 73 Eugenin (10.1016/j.nbd.2013.02.004_bb0105) 2007; 104 Agrawal (10.1016/j.nbd.2013.02.004_bb0015) 2007; 363 Jones (10.1016/j.nbd.2013.02.004_bb0190) 1998; 57 Haughey (10.1016/j.nbd.2013.02.004_bb0175) 2001; 78 Pittaluga (10.1016/j.nbd.2013.02.004_bb0290) 2007; 53 Wessenligh (10.1016/j.nbd.2013.02.004_bb0340) 1993; 33 Behnisch (10.1016/j.nbd.2013.02.004_bb0040) 2004; 1012 Modi (10.1016/j.nbd.2013.02.004_bb0245) 2002; 202 Gupta (10.1016/j.nbd.2013.02.004_bb0165) 2010; 485 Peng (10.1016/j.nbd.2013.02.004_bb0285) 2010; 218 Singer (10.1016/j.nbd.2013.02.004_bb0325) 2010; 28 Sabatier (10.1016/j.nbd.2013.02.004_bb0305) 1991; 65 Musante (10.1016/j.nbd.2013.02.004_bb0250) 2010; 20 Zucchini (10.1016/j.nbd.2013.02.004_bb0360) 2002; 13 Altavilla (10.1016/j.nbd.2013.02.004_bb0025) 1999; 154 Everall (10.1016/j.nbd.2013.02.004_bb0110) 1999; 9 Virgili (10.1016/j.nbd.2013.02.004_bb0335) 1992; 5 Muzzolini (10.1016/j.nbd.2013.02.004_bb0260) 1997; 31 Chang (10.1016/j.nbd.2013.02.004_bb0070) 1997; 12 Kim (10.1016/j.nbd.2013.02.004_bb0200) 2003; 162 Musante (10.1016/j.nbd.2013.02.004_bb0255) 2011; 117 Giulian (10.1016/j.nbd.2013.02.004_bb0150) 1990; 250 Schmued (10.1016/j.nbd.2013.02.004_bb0310) 2000; 874 |
References_xml | – volume: 45 start-page: 657 year: 2012 end-page: 670 ident: bb0020 article-title: HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes publication-title: Neurobiol. Dis. – volume: 56 start-page: 1414 year: 2008 end-page: 1427 ident: bb0065 article-title: Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice publication-title: Glia – volume: 372 start-page: 115 year: 1986 end-page: 129 ident: bb0090 article-title: A rapid method for isolation of synaptosomes on Percoll gradient publication-title: Brain Res. – volume: 104 start-page: 3434 year: 2007 end-page: 3438 ident: bb0105 article-title: HIV-tat induces formation of an LRP–PSD-95–NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytes publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 54 start-page: 19 year: 1998 end-page: 33 ident: bb0265 article-title: Neurobiological aspects of HIV infections: neurotoxic mechanisms publication-title: Prog. Neurobiol. – volume: 55 start-page: 1189 year: 1988 end-page: 1193 ident: bb0140 article-title: Cellular uptake of the Tat protein from human immunodeficiency virus publication-title: Cell – volume: 65 start-page: 961 year: 1991 end-page: 967 ident: bb0305 article-title: Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1 publication-title: J. Virol. – volume: 56 start-page: 111 year: 1999 end-page: 114 ident: bb0035 article-title: Isolated, chronic, epilepsia partialis continua in an HIV-infected patient publication-title: Arch. Neurol. – volume: 22 start-page: 10030 year: 2002 end-page: 10038 ident: bb0060 article-title: Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures publication-title: J. Neurosci. – volume: 5 start-page: 469 year: 1992 end-page: 474 ident: bb0335 article-title: Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: effect of MK-801 and CGP 39551 on neurotransmitter and glial markers publication-title: Neuropharmacology – volume: 13 start-page: 2071 year: 2002 end-page: 2074 ident: bb0360 article-title: Neuroprotective activity of CHF3381, a putative N-methyl- publication-title: NeuroReport – volume: 72 start-page: 248 year: 1976 end-page: 254 ident: bb0050 article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding publication-title: Anal. Biochem. – volume: 82 start-page: 97 year: 1998 end-page: 106 ident: bb0075 article-title: Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein publication-title: Neuroscience – volume: 23 start-page: 6810 year: 2003 end-page: 6818 ident: bb0120 article-title: The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms publication-title: J. Neurosci. – volume: 367 start-page: 368 year: 2006 ident: bb0330 article-title: Confusion, memory disorders, and ophthalmoparesis in a patient with AIDS publication-title: Lancet – volume: 250 start-page: 1593 year: 1990 end-page: 1596 ident: bb0150 article-title: Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 publication-title: Science – volume: 29 start-page: 965 year: 2004 end-page: 978 ident: bb0240 article-title: Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions publication-title: Neurochem. Res. – volume: 28 start-page: 253 year: 2010 end-page: 275 ident: bb0325 article-title: Neurological presentation of AIDS publication-title: Neurol. Clin. – volume: 85 start-page: 3657 year: 2007 end-page: 3665 ident: bb0225 article-title: N-methyl- publication-title: J. Neurosci. Res. – volume: 1 start-page: 59 year: 1996 end-page: 69 ident: bb0085 article-title: Prospective analysis of seizure occurring in human immunodeficiency virus type-1 infection publication-title: J. NeuroAIDS – volume: 285 start-page: 1569 year: 1999 end-page: 1572 ident: bb0315 article-title: In vivo protein transduction: delivery of a biologically active protein into the mouse publication-title: Science – volume: 485 start-page: 233 year: 2010 end-page: 236 ident: bb0165 article-title: HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter publication-title: Neurosci. Lett. – volume: 53 start-page: 27 year: 2007 end-page: 36 ident: bb0290 article-title: Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus publication-title: Neuropharmacology – volume: 375 start-page: 497 year: 1995 end-page: 500 ident: bb0345 article-title: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 publication-title: Nature – volume: 15 start-page: 289 year: 2005 end-page: 292 ident: bb0320 article-title: Memory loss in persons with HIV/AIDS: assessment and strategies for coping publication-title: AIDS Read. – volume: 85 start-page: 1299 year: 2003 end-page: 1311 ident: bb0100 article-title: MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis publication-title: J. Neurochem. – volume: 67 start-page: 277 year: 1993 end-page: 287 ident: bb0095 article-title: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation publication-title: J. Virol. – volume: 229 start-page: 69 year: 1985 end-page: 73 ident: bb0030 article-title: Trans-activator gene of human T-lymphotropic virus type III (HTLV-III) publication-title: Science – volume: 218 start-page: 94 year: 2010 end-page: 101 ident: bb0285 article-title: The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART publication-title: J. Neuroimmunol. – volume: 262 start-page: 114 year: 1993 end-page: 118 ident: bb0045 article-title: Functional evidence for multiple GABAB receptor subtypes in the rat cerebral cortex publication-title: J. Pharmacol. Exp. Ther. – volume: 25 start-page: 1265 year: 2000 end-page: 1274 ident: bb0300 article-title: Synaptosomes still viable after 25 publication-title: Neurochem. Res. – volume: 12 start-page: 1421 year: 1997 end-page: 1431 ident: bb0070 article-title: HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region publication-title: AIDS – volume: 31 start-page: 113 year: 1997 end-page: 124 ident: bb0260 article-title: Characterization of glutamate and [3H] publication-title: Neurochem. Int. – volume: 19 start-page: 517 year: 1986 end-page: 524 ident: bb0270 article-title: The AIDS dementia complex: I. Clinical features publication-title: Ann. Neurol. – volume: 954 start-page: 300 year: 2002 end-page: 307 ident: bb0295 article-title: Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl- publication-title: Brain Res. – volume: 78 start-page: 457 year: 2001 end-page: 467 ident: bb0175 article-title: HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity publication-title: J. Neurochem. – volume: 57 start-page: 563 year: 1998 end-page: 570 ident: bb0190 article-title: Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement publication-title: J. Neuropathol. Exp. Neurol. – volume: 49 start-page: 13112 year: 2008 end-page: 13124 ident: bb0365 article-title: FGF-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss publication-title: J. Neurosci. – volume: 5 start-page: 294 year: 2010 end-page: 309 ident: bb0215 article-title: HIV-1 associated neurocognitive disorder: pathogenesis and therapeutic opportunities publication-title: J. Neuroimmune Pharmacol. – volume: 6 start-page: 145 year: 2000 end-page: 155 ident: bb0180 article-title: Detection of human immunodeficiency virus regulatory protein Tat in CNS tissues publication-title: J. Neurovirol. – volume: 95 start-page: 13153 year: 1998 end-page: 13158 ident: bb0005 article-title: HIV-1 Tat protein mimicry of chemokines publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 73 start-page: 1363 year: 1999 end-page: 1374 ident: bb0170 article-title: Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat publication-title: J. Neurochem. – volume: 363 start-page: 462 year: 2007 end-page: 472 ident: bb0015 article-title: Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications publication-title: Virology – volume: 32 start-page: 321 year: 1992 end-page: 329 ident: bb0230 article-title: Spectrum of human immunodeficiency virus-associated neocortical damage publication-title: Ann. Neurol. – volume: 20 start-page: 1974 year: 2010 end-page: 1984 ident: bb0250 article-title: The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings publication-title: Cereb. Cortex – volume: 202 start-page: 29 year: 2002 end-page: 34 ident: bb0245 article-title: New onset seizures in HIV-infected patients without intracranial mass lesions or meningitis—a clinical, radiological and SPECT scan study publication-title: J. Neurol. Sci. – year: 2001 ident: bb0280 article-title: The Mouse Brain in Stereotaxic Coordinates – volume: 874 start-page: 123 year: 2000 end-page: 130 ident: bb0310 article-title: Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration publication-title: Brain Res. – volume: 8 start-page: 1347 year: 2006 end-page: 1357 ident: bb0205 article-title: HIV Tat and neurotoxicity publication-title: Microbes Infect. – volume: 162 start-page: 1693 year: 2003 end-page: 1707 ident: bb0200 article-title: Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline publication-title: Am. J. Pathol. – volume: 159 start-page: 1292 year: 2009 end-page: 1299 ident: bb0130 article-title: The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study publication-title: Neuroscience – volume: 305 start-page: 5 year: 2001 end-page: 8 ident: bb0010 article-title: Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum publication-title: Neurosci. Lett. – volume: 53 start-page: 5569 year: 1993 end-page: 5575 ident: bb0080 article-title: Systemic expression of HIV-1 publication-title: Cancer Res. – volume: 12 start-page: 878 year: 2005 end-page: 892 ident: bb0195 article-title: HIV-1 infection and AIDS: consequences for the central nervous system publication-title: Cell Death Differ. – volume: 329 start-page: 1071 year: 2009 end-page: 1083 ident: bb0355 article-title: HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes publication-title: J. Pharmacol. Exp. Ther. – volume: 179 start-page: 60 year: 2003 end-page: 70 ident: bb0135 article-title: Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain publication-title: Exp. Neurol. – volume: 18 start-page: 2004 year: 1998 end-page: 2008 ident: bb0185 article-title: A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine publication-title: J. Neurosci. – volume: 28 start-page: 12190 year: 2008 end-page: 12198 ident: bb0210 article-title: NMDA receptor activation by HIV-Tat protein is clade dependent publication-title: J. Neurosci. – volume: 62 start-page: 235 year: 2007 end-page: 242 ident: bb0115 article-title: Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission publication-title: Biol. Psychiatry – volume: 151 start-page: 701 year: 2008 end-page: 710 ident: bb0055 article-title: Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons publication-title: Neuroscience – volume: 317 start-page: 1097 year: 2006 end-page: 1105 ident: bb0220 article-title: The human immunodeficiency virus-1 protein Tat upregulates NMDA receptor function by acting at mGluR1 receptors coexisting on human and rat brain noradrenergic neurons publication-title: J. Pharmacol. Exp. Ther. – volume: 93 start-page: 1851 year: 1999 end-page: 1857 ident: bb0235 article-title: Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells publication-title: Blood – volume: 33 start-page: 576 year: 1993 end-page: 582 ident: bb0340 article-title: Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia publication-title: Ann. Neurol. – volume: 106 start-page: 7191 year: 2009 end-page: 7196 ident: bb0275 article-title: Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 275 start-page: 4159 year: 2000 end-page: 4165 ident: bb0350 article-title: HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells publication-title: J. Biol. Chem. – volume: 117 start-page: 516 year: 2011 end-page: 527 ident: bb0255 article-title: Presynaptic glycine GlyT1 transporter–NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg publication-title: J. Neurochem. – volume: 267 start-page: 252 year: 2000 end-page: 256 ident: bb0145 article-title: Tat mediates apoptosis in vivo in the rat central nervous system publication-title: Biochem. Biophys. Res. Commun. – volume: 8 start-page: 284 year: 2003 end-page: 294 ident: bb0125 article-title: Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time publication-title: Mol. Ther. – volume: 9 start-page: 209 year: 1999 end-page: 217 ident: bb0110 article-title: Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder publication-title: Brain Pathol. – volume: 1012 start-page: 187 year: 2004 end-page: 189 ident: bb0040 article-title: HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region publication-title: Brain Res. – volume: 154 start-page: 1231 year: 1999 end-page: 1244 ident: bb0025 article-title: Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors, dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice publication-title: Am. J. Pathol. – volume: 95 start-page: 13153 year: 1998 ident: 10.1016/j.nbd.2013.02.004_bb0005 article-title: HIV-1 Tat protein mimicry of chemokines publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.95.22.13153 – year: 2001 ident: 10.1016/j.nbd.2013.02.004_bb0280 – volume: 33 start-page: 576 year: 1993 ident: 10.1016/j.nbd.2013.02.004_bb0340 article-title: Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia publication-title: Ann. Neurol. doi: 10.1002/ana.410330604 – volume: 1 start-page: 59 year: 1996 ident: 10.1016/j.nbd.2013.02.004_bb0085 article-title: Prospective analysis of seizure occurring in human immunodeficiency virus type-1 infection publication-title: J. NeuroAIDS – volume: 31 start-page: 113 year: 1997 ident: 10.1016/j.nbd.2013.02.004_bb0260 article-title: Characterization of glutamate and [3H]d-aspartate outflow from various in vitro preparations of the rat hippocampus publication-title: Neurochem. Int. doi: 10.1016/S0197-0186(96)00129-5 – volume: 93 start-page: 1851 year: 1999 ident: 10.1016/j.nbd.2013.02.004_bb0235 article-title: Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells publication-title: Blood doi: 10.1182/blood.V93.6.1851.406k12_1851_1857 – volume: 56 start-page: 1414 year: 2008 ident: 10.1016/j.nbd.2013.02.004_bb0065 article-title: Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice publication-title: Glia doi: 10.1002/glia.20708 – volume: 62 start-page: 235 year: 2007 ident: 10.1016/j.nbd.2013.02.004_bb0115 article-title: Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2006.08.003 – volume: 13 start-page: 2071 year: 2002 ident: 10.1016/j.nbd.2013.02.004_bb0360 article-title: Neuroprotective activity of CHF3381, a putative N-methyl-d-aspartate receptor antagonist publication-title: NeuroReport doi: 10.1097/00001756-200211150-00016 – volume: 285 start-page: 1569 issue: 5433 year: 1999 ident: 10.1016/j.nbd.2013.02.004_bb0315 article-title: In vivo protein transduction: delivery of a biologically active protein into the mouse publication-title: Science doi: 10.1126/science.285.5433.1569 – volume: 329 start-page: 1071 year: 2009 ident: 10.1016/j.nbd.2013.02.004_bb0355 article-title: HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.108.150144 – volume: 485 start-page: 233 year: 2010 ident: 10.1016/j.nbd.2013.02.004_bb0165 article-title: HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2010.09.019 – volume: 12 start-page: 878 year: 2005 ident: 10.1016/j.nbd.2013.02.004_bb0195 article-title: HIV-1 infection and AIDS: consequences for the central nervous system publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4401623 – volume: 49 start-page: 13112 year: 2008 ident: 10.1016/j.nbd.2013.02.004_bb0365 article-title: FGF-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1472-08.2008 – volume: 154 start-page: 1231 year: 1999 ident: 10.1016/j.nbd.2013.02.004_bb0025 article-title: Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors, dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)65375-8 – volume: 23 start-page: 6810 year: 2003 ident: 10.1016/j.nbd.2013.02.004_bb0120 article-title: The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.23-17-06810.2003 – volume: 78 start-page: 457 year: 2001 ident: 10.1016/j.nbd.2013.02.004_bb0175 article-title: HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2001.00396.x – volume: 29 start-page: 965 year: 2004 ident: 10.1016/j.nbd.2013.02.004_bb0240 article-title: Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions publication-title: Neurochem. Res. doi: 10.1023/B:NERE.0000021241.90133.89 – volume: 218 start-page: 94 issue: 1–2 year: 2010 ident: 10.1016/j.nbd.2013.02.004_bb0285 article-title: The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART publication-title: J. Neuroimmunol. doi: 10.1016/j.jneuroim.2009.09.014 – volume: 5 start-page: 469 year: 1992 ident: 10.1016/j.nbd.2013.02.004_bb0335 article-title: Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: effect of MK-801 and CGP 39551 on neurotransmitter and glial markers publication-title: Neuropharmacology doi: 10.1016/0028-3908(92)90085-4 – volume: 1012 start-page: 187 year: 2004 ident: 10.1016/j.nbd.2013.02.004_bb0040 article-title: HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region publication-title: Brain Res. doi: 10.1016/j.brainres.2004.03.037 – volume: 20 start-page: 1974 year: 2010 ident: 10.1016/j.nbd.2013.02.004_bb0250 article-title: The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings publication-title: Cereb. Cortex doi: 10.1093/cercor/bhp274 – volume: 65 start-page: 961 year: 1991 ident: 10.1016/j.nbd.2013.02.004_bb0305 article-title: Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1 publication-title: J. Virol. doi: 10.1128/JVI.65.2.961-967.1991 – volume: 104 start-page: 3434 year: 2007 ident: 10.1016/j.nbd.2013.02.004_bb0105 article-title: HIV-tat induces formation of an LRP–PSD-95–NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytes publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0611699104 – volume: 8 start-page: 1347 year: 2006 ident: 10.1016/j.nbd.2013.02.004_bb0205 article-title: HIV Tat and neurotoxicity publication-title: Microbes Infect. doi: 10.1016/j.micinf.2005.11.014 – volume: 202 start-page: 29 year: 2002 ident: 10.1016/j.nbd.2013.02.004_bb0245 article-title: New onset seizures in HIV-infected patients without intracranial mass lesions or meningitis—a clinical, radiological and SPECT scan study publication-title: J. Neurol. Sci. doi: 10.1016/S0022-510X(02)00155-7 – volume: 874 start-page: 123 year: 2000 ident: 10.1016/j.nbd.2013.02.004_bb0310 article-title: Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration publication-title: Brain Res. doi: 10.1016/S0006-8993(00)02513-0 – volume: 57 start-page: 563 issue: 6 year: 1998 ident: 10.1016/j.nbd.2013.02.004_bb0190 article-title: Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement publication-title: J. Neuropathol. Exp. Neurol. doi: 10.1097/00005072-199806000-00004 – volume: 375 start-page: 497 year: 1995 ident: 10.1016/j.nbd.2013.02.004_bb0345 article-title: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 publication-title: Nature doi: 10.1038/375497a0 – volume: 151 start-page: 701 year: 2008 ident: 10.1016/j.nbd.2013.02.004_bb0055 article-title: Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.11.031 – volume: 305 start-page: 5 issue: 1 year: 2001 ident: 10.1016/j.nbd.2013.02.004_bb0010 article-title: Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum publication-title: Neurosci. Lett. doi: 10.1016/S0304-3940(01)01786-4 – volume: 53 start-page: 27 year: 2007 ident: 10.1016/j.nbd.2013.02.004_bb0290 article-title: Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2007.04.006 – volume: 85 start-page: 1299 year: 2003 ident: 10.1016/j.nbd.2013.02.004_bb0100 article-title: MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2003.01775.x – volume: 54 start-page: 19 year: 1998 ident: 10.1016/j.nbd.2013.02.004_bb0265 article-title: Neurobiological aspects of HIV infections: neurotoxic mechanisms publication-title: Prog. Neurobiol. doi: 10.1016/S0301-0082(97)00053-1 – volume: 22 start-page: 10030 year: 2002 ident: 10.1016/j.nbd.2013.02.004_bb0060 article-title: Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.22-22-10030.2002 – volume: 372 start-page: 115 year: 1986 ident: 10.1016/j.nbd.2013.02.004_bb0090 article-title: A rapid method for isolation of synaptosomes on Percoll gradient publication-title: Brain Res. doi: 10.1016/0006-8993(86)91464-2 – volume: 9 start-page: 209 year: 1999 ident: 10.1016/j.nbd.2013.02.004_bb0110 article-title: Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder publication-title: Brain Pathol. doi: 10.1111/j.1750-3639.1999.tb00219.x – volume: 73 start-page: 1363 year: 1999 ident: 10.1016/j.nbd.2013.02.004_bb0170 article-title: Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.1999.0731363.x – volume: 67 start-page: 277 year: 1993 ident: 10.1016/j.nbd.2013.02.004_bb0095 article-title: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation publication-title: J. Virol. doi: 10.1128/JVI.67.1.277-287.1993 – volume: 262 start-page: 114 year: 1993 ident: 10.1016/j.nbd.2013.02.004_bb0045 article-title: Functional evidence for multiple GABAB receptor subtypes in the rat cerebral cortex publication-title: J. Pharmacol. Exp. Ther. – volume: 55 start-page: 1189 year: 1988 ident: 10.1016/j.nbd.2013.02.004_bb0140 article-title: Cellular uptake of the Tat protein from human immunodeficiency virus publication-title: Cell doi: 10.1016/0092-8674(88)90263-2 – volume: 117 start-page: 516 year: 2011 ident: 10.1016/j.nbd.2013.02.004_bb0255 article-title: Presynaptic glycine GlyT1 transporter–NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2011.07223.x – volume: 28 start-page: 253 year: 2010 ident: 10.1016/j.nbd.2013.02.004_bb0325 article-title: Neurological presentation of AIDS publication-title: Neurol. Clin. doi: 10.1016/j.ncl.2009.09.018 – volume: 267 start-page: 252 issue: 1 year: 2000 ident: 10.1016/j.nbd.2013.02.004_bb0145 article-title: Tat mediates apoptosis in vivo in the rat central nervous system publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1999.1894 – volume: 5 start-page: 294 year: 2010 ident: 10.1016/j.nbd.2013.02.004_bb0215 article-title: HIV-1 associated neurocognitive disorder: pathogenesis and therapeutic opportunities publication-title: J. Neuroimmune Pharmacol. doi: 10.1007/s11481-010-9205-z – volume: 317 start-page: 1097 year: 2006 ident: 10.1016/j.nbd.2013.02.004_bb0220 article-title: The human immunodeficiency virus-1 protein Tat upregulates NMDA receptor function by acting at mGluR1 receptors coexisting on human and rat brain noradrenergic neurons publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.105.099630 – volume: 179 start-page: 60 issue: 1 year: 2003 ident: 10.1016/j.nbd.2013.02.004_bb0135 article-title: Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain publication-title: Exp. Neurol. doi: 10.1006/exnr.2002.8048 – volume: 82 start-page: 97 year: 1998 ident: 10.1016/j.nbd.2013.02.004_bb0075 article-title: Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein publication-title: Neuroscience doi: 10.1016/S0306-4522(97)00174-7 – volume: 162 start-page: 1693 year: 2003 ident: 10.1016/j.nbd.2013.02.004_bb0200 article-title: Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)64304-0 – volume: 19 start-page: 517 year: 1986 ident: 10.1016/j.nbd.2013.02.004_bb0270 article-title: The AIDS dementia complex: I. Clinical features publication-title: Ann. Neurol. doi: 10.1002/ana.410190602 – volume: 12 start-page: 1421 year: 1997 ident: 10.1016/j.nbd.2013.02.004_bb0070 article-title: HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region publication-title: AIDS doi: 10.1097/00002030-199712000-00006 – volume: 56 start-page: 111 year: 1999 ident: 10.1016/j.nbd.2013.02.004_bb0035 article-title: Isolated, chronic, epilepsia partialis continua in an HIV-infected patient publication-title: Arch. Neurol. doi: 10.1001/archneur.56.1.111 – volume: 159 start-page: 1292 year: 2009 ident: 10.1016/j.nbd.2013.02.004_bb0130 article-title: The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study publication-title: Neuroscience doi: 10.1016/j.neuroscience.2009.01.024 – volume: 28 start-page: 12190 year: 2008 ident: 10.1016/j.nbd.2013.02.004_bb0210 article-title: NMDA receptor activation by HIV-Tat protein is clade dependent publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3019-08.2008 – volume: 32 start-page: 321 year: 1992 ident: 10.1016/j.nbd.2013.02.004_bb0230 article-title: Spectrum of human immunodeficiency virus-associated neocortical damage publication-title: Ann. Neurol. doi: 10.1002/ana.410320304 – volume: 363 start-page: 462 year: 2007 ident: 10.1016/j.nbd.2013.02.004_bb0015 article-title: Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications publication-title: Virology doi: 10.1016/j.virol.2007.02.004 – volume: 8 start-page: 284 year: 2003 ident: 10.1016/j.nbd.2013.02.004_bb0125 article-title: Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time publication-title: Mol. Ther. doi: 10.1016/S1525-0016(03)00122-9 – volume: 45 start-page: 657 year: 2012 ident: 10.1016/j.nbd.2013.02.004_bb0020 article-title: HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2011.10.005 – volume: 6 start-page: 145 year: 2000 ident: 10.1016/j.nbd.2013.02.004_bb0180 article-title: Detection of human immunodeficiency virus regulatory protein Tat in CNS tissues publication-title: J. Neurovirol. doi: 10.3109/13550280009013158 – volume: 275 start-page: 4159 issue: 6 year: 2000 ident: 10.1016/j.nbd.2013.02.004_bb0350 article-title: HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.275.6.4159 – volume: 106 start-page: 7191 year: 2009 ident: 10.1016/j.nbd.2013.02.004_bb0275 article-title: Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0810710106 – volume: 25 start-page: 1265 year: 2000 ident: 10.1016/j.nbd.2013.02.004_bb0300 article-title: Synaptosomes still viable after 25years of superfusion publication-title: Neurochem. Res. doi: 10.1023/A:1007648229795 – volume: 954 start-page: 300 year: 2002 ident: 10.1016/j.nbd.2013.02.004_bb0295 article-title: Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor publication-title: Brain Res. doi: 10.1016/S0006-8993(02)03360-7 – volume: 72 start-page: 248 year: 1976 ident: 10.1016/j.nbd.2013.02.004_bb0050 article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding publication-title: Anal. Biochem. doi: 10.1016/0003-2697(76)90527-3 – volume: 85 start-page: 3657 year: 2007 ident: 10.1016/j.nbd.2013.02.004_bb0225 article-title: N-methyl-d-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus publication-title: J. Neurosci. Res. doi: 10.1002/jnr.21446 – volume: 53 start-page: 5569 year: 1993 ident: 10.1016/j.nbd.2013.02.004_bb0080 article-title: Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes publication-title: Cancer Res. – volume: 229 start-page: 69 year: 1985 ident: 10.1016/j.nbd.2013.02.004_bb0030 article-title: Trans-activator gene of human T-lymphotropic virus type III (HTLV-III) publication-title: Science doi: 10.1126/science.2990040 – volume: 18 start-page: 2004 year: 1998 ident: 10.1016/j.nbd.2013.02.004_bb0185 article-title: A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.18-06-02004.1998 – volume: 250 start-page: 1593 year: 1990 ident: 10.1016/j.nbd.2013.02.004_bb0150 article-title: Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 publication-title: Science doi: 10.1126/science.2148832 – volume: 15 start-page: 289 year: 2005 ident: 10.1016/j.nbd.2013.02.004_bb0320 article-title: Memory loss in persons with HIV/AIDS: assessment and strategies for coping publication-title: AIDS Read. – volume: 367 start-page: 368 year: 2006 ident: 10.1016/j.nbd.2013.02.004_bb0330 article-title: Confusion, memory disorders, and ophthalmoparesis in a patient with AIDS publication-title: Lancet doi: 10.1016/S0140-6736(06)68075-6 |
SSID | ssj0011597 |
Score | 2.2737892 |
Snippet | HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood... Abstract HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely... |
SourceID | doaj proquest pubmed crossref elsevier |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 110 |
SubjectTerms | Analysis of Variance Animals Brain - drug effects Brain - metabolism Brain - pathology Brain - virology Disease Models, Animal Dose-Response Relationship, Drug Gene Products, tat - pharmacology HIV-1 associated neurocognitive disorders HIV-1-tat-transgenic mice Human immunodeficiency virus 1 Kainate Kainic Acid - toxicity Male Mice Mice, Transgenic Nervous System Diseases - pathology Nervous System Diseases - virology Neurodegeneration Neurology Neurotransmitter Agents - metabolism Seizures Seizures - chemically induced Seizures - physiopathology Statistics, Nonparametric tat Gene Products, Human Immunodeficiency Virus - genetics tat Gene Products, Human Immunodeficiency Virus - metabolism Vesicular Glutamate Transport Proteins - metabolism |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLgpZHykOuhDggRSSOHcfcCmq1rVQOQFFvZuKHtKhkK3Yr0X_PjOOsqNRuLxx3dxyvPDOeb-LxN4y9cS20EgwmOdDT2ypTl6ZRujQRjJMxQujogvPJ53Z2Ko_P1Nk_rb6oJmykBx4X7r3yvgJTdx6BrzRRGwB8DAIRIF7l1K9WVKaakql8foBBWk9nmKmaa-iJFrRuRoJOeS0KJbL-a8HoNrCZgs7hI_Ywo0W-P_7Lx-xeGLbZzv6AmfKvK_6Wp_rN9GJ8m90_ycfkO-wHej0VmwfPwx-H2X-qgL3i84EjtixXFJ_QcOaOUzP6D_zL4jzwRaQfSWZ29L1Md1xwfOK7zPsj95mqc_mEnR4efPs0K3MrhdIholmVrVdd3wJ4yqCga1un2yijQAVpANl4KSJ-il3TeONBGNxAe18piE70oRPNU7Y1LIbwnPGISx8gxDqqXgbM1jz6tMYtv1fCgdEFq6altS7zjFO7i3M7FZT9tKgNS9qwlbCojYK9Ww-5GEk2Ngl_JH2tBYkfO32BVmOz1di7rKZgYtK2na6g4qaJD5pvmlnfNCgss9svbW2XKGm_Yl5IiWRNZ4WI6eqCyfXIjGxGxHLXhHuTIVr0ejrKgSEsLnGiRhqdiD43yCjCf6ozXcGejVa8XjTRSCURu-_-j8V8wR6I1CSEiphfsq3V78vwCqHaqn-dvPIvocM6VQ priority: 102 providerName: Directory of Open Access Journals |
Title | Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0969996113000661 https://www.clinicalkey.es/playcontent/1-s2.0-S0969996113000661 https://dx.doi.org/10.1016/j.nbd.2013.02.004 https://www.ncbi.nlm.nih.gov/pubmed/23454193 https://www.proquest.com/docview/1349704722 https://www.proquest.com/docview/1500785898 https://doaj.org/article/5dd0a918d97449f79aafa9045a083613 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJyFeEGzAAqwyEuIBKbRx7CTmrauYOmATGgztzTixjYJGMq2dxF7427lznEgVUCQem57jyHe-D9_dz4Q8rzKdcS0hyNElnlbJJJapyGPptKy4c9oW2OB8fJItzvjbc3G-ReZ9LwyWVQbd3-l0r63Dk0lYzcllXU8-gvON3nqCCRkwnBACbTOw9sWIbM-O3i1OhmQCWGzfNQ30MQ7ok5u-zKspES80STvkTr5mnjyK_5qV-psX6q3R4T1yN7iRdNZ96X2yZZsdsjtrIIT-fkNfUF_Y6U_Md8jt45A_3yVfQB1gFbo11P6o6lUH0n1D64aC0xmv0HCBRNUVxVvqX9PT9sLS1uGfSLM4-hz75hcY74Ewg-KkJmB4Lh-Qs8M3n-aLONyxEFfg6qzizIiizLQ2GFrpIsuqPHPcMeBcrjVPDWcOfrkiTY00mknQrKWZCu0qVtqCpQ_JqGkbu0eo40JbbV3iRMkthHEGNnsOtqAUrNIyj8i0X1pVBQByvAfjQvWVZt8UcEMhN9SUKeBGRF4OQy479I1NxAfIr4EQgbP9g_bqqwqSo4QxUy2TwkAcxaXLpdYgleDXaoTpTtKIsJ7bqu9NBW0KL6o3zZz_aZBdBn2wVIlaAqX6TWYjwoeRa2L_rwmf9YKoQB1gjkc3tr2GiVIuc48AuoFGoGMoCllE5FEnxcOisZQLDk794__7sCfkDvP3hWA981MyWl1d233w2lblmNx69TMZw96cn77_MA57dOzPQH4BBh1BmQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqrQRcELQ8Ul5GQhyQot04zsPclooqS7t7gBb1ZpzYRkFtUnVTif57Zhwn0gpYJI5JZuLIM55HPP6GkDdVqlKuBCQ5qsS_VSIKRZxkobBKVNxaZXI84LxcpcUZ_3SenO-Qw-EsDJZVetvf23Rnrf2dqZ_N6VVdT79A8I3ReoQbMuA4IQXa5djUekJ254vjYjVuJoDHdqemgT5EhmFz05V5NSXihUZxj9zJN9yTQ_Hf8FJ_i0KdNzp6QO77MJLO-y99SHZMs0f25w2k0Je39C11hZ3uj_keubP0--f75BuYA6xCN5qan1Xd9SDdt7RuKASdYYeOCzSqrih2qX9PP7cXhrYWHyJNsfgausMvwO-AML3hpNpjeK4fkbOjj6eHReh7LIQVhDpdmOokL1OlNKZWKk_TKksttwwklynFY82ZhSubx7EWWjEBlrXUs0TZipUmZ_FjMmnaxjwl1PJEGWVsZJOSG0jjNCz2DHxBmbBKiSwgs2FqZeUByLEPxoUcKs1-SJCGRGnIGZMgjYC8G1muevSNbcQfUF4jIQJnuxvt9XfpNUcmWs-UiHINeRQXNhNKgVZCXKsQpjuKA8IGacvhbCpYU3hRvW3k7E9MZu3twVpGcg2U8jedDQgfOTfU_l8Dvh4UUYI5wD0e1Zj2BgaKucgcAugWmgQDwyQXeUCe9Fo8ThqLcQ2J-OD_PuwVuVucLk_kyWJ1_IzcY653CNY2PyeT7vrGvIAIritf-hX6C_8GQPU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+excitability+in+tat-transgenic+mice%3A+Role+of+tat+in+HIV-related+neurological+disorders&rft.jtitle=Neurobiology+of+disease&rft.au=Zucchini%2C+Silvia&rft.au=Pittaluga%2C+Anna&rft.au=Brocca-Cofano%2C+Egidio&rft.au=Summa%2C+Maria&rft.date=2013-07-01&rft.issn=0969-9961&rft.volume=55&rft.spage=110&rft.epage=119&rft_id=info:doi/10.1016%2Fj.nbd.2013.02.004&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_nbd_2013_02_004 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09699961%2FS0969996113X00063%2Fcov150h.gif |